Related Experiment Videos

[Administration of MR contrast agents outside of approved indications (off-label use]

M V Knopp1, M Lodemann, U Kage

  • 1Forschungsschwerpunkt Radiologische Diagnostik und Therapie, Deutsches Krebsforschungszentrum (dkfz), Im Neuenheimer Feld 280, 69120 Heidelberg. M.Knopp@dkfz.de

Der Radiologe
|April 27, 2001
PubMed
Abstract

Insights

Off-label use of MRI contrast agents is common but raises concerns. This paper clarifies the medical, legal, and billing aspects to enhance physician understanding and confidence in these crucial procedures.

Area of Science:

  • Radiology
  • Medical Imaging

Context:

  • Off-label use of MRI contrast agents is a routine practice in radiology.
  • Physicians often experience unease regarding these uses.

Purpose:

  • To address the medical, juridicial, and billing issues associated with off-label MRI contrast agent use.
  • To improve physician knowledge and reduce apprehension.

Summary:

  • Off-label use is permissible under specific conditions and can represent the current medical standard.
  • Physician prerogative, rooted in the Declaration of Helsinki, forms the basis for off-label utilization.

Impact:

  • The demand for off-label MRI contrast agent applications is expected to grow.
  • High costs of clinical trials for registration encourage manufacturers to focus on essential indications.

Related Concept Videos